ReviewCurrent psychiatry reports2020
Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies.
Review in Current psychiatry reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.
- Pharmacological interventions for people with borderline personality disorder.The Cochrane database of systematic reviews · 2022Pooled it
- Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.CNS drugs · 2021Pooled it
- Pharmacological interventions for self-harm in adults.The Cochrane database of systematic reviews · 2021Pooled it
- A randomised study and an extension study of brexpiprazole in patients with borderline personality disorder.Acta neuropsychiatrica · 2024Trial
- A pilot randomized controlled trial of ketamine in Borderline Personality Disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023Trial
- Variations in maladaptive personality patterns and depressive symptoms' severity across personality functioning profiles in a community sample.Scientific reports · 2026Article
- Facial emotion processing in patients with borderline personality disorder as compared with healthy controls: an fMRI and ECG study.Borderline personality disorder and emotion dysregulation · 2024Article
- Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?Frontiers in psychiatry · 2024Review
- Article
- Assessing the quality of the care offer for people with personality disorders in Italy: the QUADIM project. A multicentre research based on the database of use of Mental Health services.International journal of mental health systems · 2023Article
- Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder.JAMA network open · 2023Article
- Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec's health services register cohort.Frontiers in psychiatry · 2023Article
- Associations between antipsychotics and risk of violent crimes and suicidal behaviour in personality disorder.Evidence-based mental health · 2022Article
- Should psychiatrists be more cautious about the use of antipsychotics for patients with borderline personality disorder?Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) · 2022Article
- The screen for cognitive impairment in psychiatry in patients with borderline personality disorder.Personality and mental health · 2022Article
- Association between quetiapine use and self-harm outcomes among people with recorded personality disorder in UK primary care: A self-controlled case series analysis.Journal of psychopharmacology (Oxford, England) · 2022Article
- MDMA-Assisted Psychotherapy for Borderline Personality Disorder.Focus (American Psychiatric Publishing) · 2022Review
- The societal cost of treatment-seeking patients with borderline personality disorder in Germany.European archives of psychiatry and clinical neuroscience · 2022Article
- The State of Overmedication in Borderline Personality Disorder: Interpersonal and Structural Factors.Current treatment options in psychiatry · 2022Article
- Efficacy and safety of cariprazine augmentation in patients treated with clozapine: a pilot study.Therapeutic advances in psychopharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewWe aim to identify the most recent evidence of randomised controlled trials evaluating continued drug treatments in people with a diagnosis of BPD, review the most recent findings, highlight trends in terms of currently ongoing studies and comment on the overall body of evidence. RECENT
findingsWe identified seven new RCTs, plus newly available data for an older RCT. Only three of these RCTs have been published in full text, while we found study data posted at trial registry platforms for the others. The new findings do not support fluoxetine as a treatment option for suicide and self-harm prevention. A large effectiveness study did not detect beneficial effects of lamotrigine in routine care. The prevalent use of medications in BPD is still not reflected or supported by the current evidence. More research is needed regarding the most commonly used substances and substance classes, i.e. SSRIs, and quetiapine, but also with respect to people presenting with distinct comorbid conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.